CV S. Deville-Foillard

2018-now
CNRS Researcher CRCN at ICSN – Université Paris-Saclay
2013-2017 CNRS Researcher CRCN at Institut Curie – Université Paris (PSL).
2012-2013 Post-doctoral Fellow at ESPCI – Paris (Dr B. Dubertret).
2010-2012 Post-doctoral Fellow at CEA in collaboration with IPSEN – Saclay (Dr M. Paternostre).
2008-2012 Post-doctoral Fellow at CEA – Saclay (Dr E. Doris).
2005-2008 PhD at DCM – Université Grenoble Alpes (Pr P. Dumy)

Molecular Engineering

Peptide synthesis

Targeted strategy for drug delivery and imaging

15 publications – 1 patents.

7 oral communications.

6 poster communications

  1. Foillard, S.; Russier, J.; Seifert, C.; Dumortier, H.; Doris, E. Carbon nanotube-mediated delivery of Budesonide to macrophages.  RSC Adv, 2016, 6, 53282-53287.
  2. Canape, C.; Foillard, S.; Bonafe, R.; Maiocchi A.; Doris, E.  Comparative assessment of the in vitro toxicity of some functionalized carbon nanotubes and fullerenes. RSC Adv, 2015, 5, 68446-68453.
  3. Valéry, C.*; Deville-Foillard, S.*; Lefebvre, C.; Taberner, N.; Legrand, P.; Meneau, F.; Meriadec, C.; Delvaux, C.; Bizien, T.; Kasotakis, E.; Lopez-Iglesias, C.; Gall, A.; Bressanelli, S.; Le Du, M.-H.; Paternostre, M.; Artzner, F. Atomic view of the histidine environment stabilizing higher-pH conformations of pH-dependent proteins. Nat Commun 2015, 6, 7771-7779.
  4. Varkouhi, A.K.; Foillard, S.; Lammers, T.; Schiffelers, R.M.; Doris, E.; Hennink, W.E.; Storm, G. SiRNA delivery with functionalized carbon nanotubes. Int J Pharm 2011, 416, 419-425.
  5. Foillard, S.; Zuber, G.; Doris, E. Polyethylenimine-carbon nanotube nanohybrids for siRNA-mediated gene silencing at cellular level. Nanoscale 2011, 3, 1461-1464.
  6. Dufort, S.; Sancey, L.; Hurbin, A.; Foillard, S.; Boturyn, D.; Dumy, P.; Coll, J.L. Targeted delivery of a proapoptotic peptide to tumors in vivo. J Drug Target 2011, 19, 582-588.
  7. Foillard, S.; Boturyn, D.; Dumy, P. Highly efficient cell adhesion on beads functionalized with clustered peptide ligands. Org Biomol Chem 2009, 7, 4159-4162.
  8. Sancey, L.; Dufort, S.; Josserand, V.; Keramidas, M.; Rome, C.; Faure, A.-C.; Foillard, S.; Roux, S.; Boturyn, D.; Tillement, O.; Koenig, A.; Boutet, J.; Rizo, P.; Dumy, P.; Coll, J.-L. Drug development in oncology assisted by noninvasive optical imaging. Int J Pharm 2009, 2, 309-316.
  9. Foillard, S.; Sancey, L.; Coll, J.-L.; Boturyn, D.; Dumy, P. Targeted delivery of activatable fluorescent pro-apoptotic peptide into live cells. Org Biomol Chem 2009, 7, 221-224.
  10. Sancey, L.; Garanger, E.; Foillard, S.; Schoehn, G.; Hurbin, A.; Albiges-Rizo, C.; Boturyn, D.; Souchier, C.; Grichine, A.; Dumy, P.; Coll, J.-L. Clustering and internalization of integrin αvβ3 with a tetrameric RGD-synthetic peptide. Molecular Therapy 2009, 17, 837-843.
  11. Foillard, S.; Jin, Z.-H.; Garanger, E.; Boturyn, D.; Favrot, M.-C.; Coll, J.-L.; Dumy, P. Synthesis and biological characterisation of targeted pro-apoptotic peptide. Chembiochem 2008, 9, 2326-2332.
  12. Foillard, S.; Ohsten Rasmussen, M.; Razkin, J.; Boturyn, D.; Dumy, P. 1-Ethoxyethylidene, a New Compatible Protecting Group for the Stepwise SPPS of Aminooxy Peptides. J Org Chem 2008, 73, 983-991.
  13. Jin, Z.-H.; Josserand, V.; Foillard, S.; Boturyn, D.; Dumy, P.; Favrot, M.-C.; Coll, J.-L. In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors. Mol Cancer 2007, 6, 41-50

A. Volk (IGR, Univ. Paris-Saclay)

V. Semetey (IRCP, Univ. Paris PSL)

F. Schmidt/L. Johannes (Inst. Curie, Univ. Paris PSL)

Elected council member of Laboratory at ICSN

Member of the « bibliographic seminars committee »

CNRS Researcher CRCN 

ICSN-CNRS Bât. 27

1, avenue de la Terrasse

91190 Gif-sur-Yvette France

Stephanie.DEVILLE-FOILLARD@cnrs.fr

+33 1 69 82 30 59